Gene: ANGPT1
Official Full Name: angiopoietin 1provided by HGNC
Gene Summary: This gene encodes a secreted glycoprotein that belongs to the angiopoietin family. Members of this family play important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The protein encoded by this gene is a secreted glycoprotein that activates the receptor by inducing its tyrosine phosphorylation. It plays a critical role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme and inhibits endothelial permeability. The protein also contributes to blood vessel maturation and stability, and may be involved in early development of the heart. Mutations in this gene are associated with hereditary angioedema. [provided by RefSeq, Aug 2020]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09060 | ANGPT1 Knockout cell line (HEK293) | Human | ANGPT1 | 1:3~1:6 | Negative | Online Inquiry |
ANGPT1 Gene Knockout Cell Lines are specialized cellular models engineered to specifically disrupt the expression of the ANGPT1 (angiopoietin-1) gene. This gene plays a pivotal role in various physiological processes, including vascular development, angiogenesis, and tissue homeostasis. By utilizing CRISPR/Cas9 or similar genome editing technologies, these knockout cell lines provide researchers with a powerful tool to investigate the functional implications of ANGPT1 loss in cellular and molecular contexts.
The primary function of ANGPT1 is to bind to the Tie2 receptor on endothelial cells, which is crucial for promoting cell survival, migration, and proliferation during angiogenesis. By studying the ANGPT1 knockout lines, scientists can elucidate the mechanisms underlying the vascular defect and inflammatory responses resulting from ANGPT1 deficiency, providing insights into disease states such as cancer, cardiovascular diseases, and diabetes.
The scientific importance of these knockout cell lines extends into both basic and translational research. In oncology, understanding the migration and invasion of tumor cells with respect to altered angiogenesis is critical. Clinicians can leverage these models to develop targeted therapeutics aimed at enhancing or inhibiting angiogenic processes influenced by ANGPT1, paving the way for innovative treatment strategies.
Unlike alternative models that may not capture the complete biological context of ANGPT1 dysfunction, these knockout cell lines offer precise gene targeting and reproducibility. Their generation and validation ensure high specificity and fidelity, allowing for more reliable data interpretation.
For researchers and clinicians seeking to understand or manipulate the angiogenic pathway, ANGPT1 Gene Knockout Cell Lines present a unique opportunity. They facilitate groundbreaking research and pave the way for novel clinical applications by elucidating the complex interplay between angiogenesis and various pathologies.
At [Your Company Name], we pride ourselves on our expertise in the development of cutting-edge biological models, ensuring that our products meet the highest standards of quality and reliability to support your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.